WHO seeks more clarification to decide on Covaxin EUL
The WHO's Technical Advisory Group in a meeting on Tuesday agreed to conduct the final risk assessment after receiving additional data from the manufacturer.
The WHO's Technical Advisory Group in a meeting on Tuesday agreed to conduct the final risk assessment after receiving additional data from the manufacturer.
Bharat Biotech said the study enrolled participants between 18-98 years, 2,433 over the age of 60 and 4,500 with comorbidities
The vaccine maker has received a purchase order of 55 lakh doses from the Centre though it is yet to complete phase III clinical trials after receiving emergency authorization.
The team met Bharat Biotech CMD Dr Krishna Ella on 7 and 8 January at the Genome Valley in Hyderabad and they were joined virtually by the Brazilian ambassador to India, Andre Aranha Correa do Lago.
Chhattisgarh government will not allow Covaxine in the state and will not accept it if the central government sends it to us, he said.
Interacting with Health ministers of States/UTs to review preparedness and seek their personal leadership in glitch-free dry run of 8 January, Dr Harsh Vardhan urged all State health ministers to personally keep tab on disinformation regarding the approved vaccines
All the patients administered Covaxin will be tracked and monitored as if they are participating in a trial.
Oxford Institute vaccine Covishield which is being developed by Pune based Serum Institute and Bharat Biotech's Covaxin has been approved by Drug Controller General of India (DCGI) on Sunday for emergency use for immunisation against Covid-19.
